Tomas Leanderson (Former)
1 – 10 of 84
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Pharmacologic exhaustion of suppressor cells with tasquinimod enhances bacterial clearance during tuberculosis
(
- Contribution to journal › Letter
- 2018
-
Mark
Induction of S100A9 homodimer formation in vivo
(
- Contribution to journal › Article
-
Mark
Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation
(
- Contribution to journal › Article
-
Mark
Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse
(
- Contribution to journal › Article
- 2017
-
Mark
Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2016
-
Mark
IgA Structure Variations Associate with Immune Stimulations and IgA Mesangial Deposition.
(
- Contribution to journal › Article
-
Mark
CD14 is a co-receptor for TLR4 in the S100A9-induced pro-inflammatory response in monocytes
(
- Contribution to journal › Article
-
Mark
The anti-tumor effect of the quinoline-3-carboxamide tasquinimod : Blockade of recruitment of CD11b+ Ly6Chi cells to tumor tissue reduces tumor growth
(
- Contribution to journal › Article
-
Mark
Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Platelet-derived S100A8/A9 and cardiovascular disease in systemic lupus erythematosus.
2016) In Arthritis & Rheumatology(
- Contribution to journal › Article